The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase II trial of olaparib and ceralasertib in patients with recurrent osteosarcoma: Lung-only resectable cohort efficacy and correlative biomarker results.
 
Suzanne Forrest
No Relationships to Disclose
 
Amanda Marinoff
No Relationships to Disclose
 
J. Livingston
Consulting or Advisory Role - Ipsen
Research Funding - Exelixis (Inst); Genentech/Roche (Inst)
Travel, Accommodations, Expenses - Ipsen
Other Relationship - Guidepoint Global
 
Kieuhoa Vo
No Relationships to Disclose
 
Julia Glade Bender
Consulting or Advisory Role - Renaissance Pharma; SpringWorks Therapeutics
Research Funding - Bayer (Inst); Cellectar (Inst); Eisai (Inst); Jazz Pharmaceuticals (Inst); Jazz Pharmaceuticals (Inst); Lilly (Inst); Loxo (Inst); Merck (Inst); Roche/Genentech (Inst)
Patents, Royalties, Other Intellectual Property - Patent on a T lympboblastic lymphoma cell line, CUTLL1
Travel, Accommodations, Expenses - Amgen (Inst); Bayer (Inst); Eisai (Inst)
(OPTIONAL) Uncompensated Relationships - Bristol-Myers Squibb; Eisai; Merck; Pfizer; SpringWorks Therapeutics
 
Emily Blair
No Relationships to Disclose
 
Simon Smith
Employment - AstraZeneca
Stock and Other Ownership Interests - AstraZeneca
 
Neel Shah
Employment - AstraZeneca
Stock and Other Ownership Interests - AstraZeneca
 
Ketki Bhushan
No Relationships to Disclose
 
Nan Chen
No Relationships to Disclose
 
Wendy London
Consulting or Advisory Role - Jubilant Radiopharma; Memorial Sloan-Kettering Cancer Center
Research Funding - Aileron Therapeutics; Bluebird Bio; Bristol-Myers Squibb; Novartis
 
Alejandro Sweet-Cordero
No Relationships to Disclose
 
Katherine Janeway
Consulting or Advisory Role - Recordati
Research Funding - AstraZeneca (Inst); Eisai (Inst)